Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Wan-Tong Yao
Based on 11 articles published since 2008
||||
Expertise Level
The expertise of Wan-Tong Yao ranks in the
  • Top 0.86%
  • ... of 94,906 published authors worldwide on Pancreatic Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Yao, W-T   ·   Yao, Wan-Tong   ·   Yao, Wantong
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2016
  • Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA; · Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Sheikh Ahmed Pancreatic Cancer Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 26883357
  • Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. Electronic address: · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epigenetics and Molecular Carcinogenesis, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan 20139, Italy. · Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan 20139, Italy. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. Electronic address: · C-4 Therapeutics, Cambridge, MA 02142, USA. Electronic address: · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27320920
2015
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of System Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25736685
2014
  • 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [3]. · Department of Medicine, Weill Cornell Medical College, New York, New York 10065, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [3] Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pathology Unit, San Raffaele Scientific Institute, Milan 20132, Italy. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine, Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 25119024
  • Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, U.K. · Swiss Institute for Experimental Cancer Research (ISREC), The Swiss Federal Institute of Technology Lausanne (EPFL), Station 19, CH-1015 Lausanne, Switzerland. · Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Biochemistry and Molecular Biology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Cancer Biology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 24954535
Probable:    Fudan University      
2014
  • 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China [3] Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. · Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. · State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, Nanjing, China. · Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. · Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · College of Pharmacy, Seoul National University, Seoul, Korea. · AntiCancer Biotech Beijing Co. Ltd, Beijing, China. · Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Surgery, University of California, San Diego, CA, USA [2] AntiCancer, Inc., San Diego, CA, USA. · Pubmed 24525735
2014
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, 270 DongAn Road, Shanghai 200032, P, R, China. · Pubmed 25103363
2013
  • Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China E-mail : · Pubmed 24083692
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China. · Pubmed 23588667
2012
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University, Shanghai Cancer Center, Shanghai 200032, China. · Pubmed 22138436
  • Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · Pubmed 22354009
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Wan-Tong Yao about Pancreatic Neoplasms:

  • Genetics and biology of pancreatic ductal adenocarcinoma. 2016
  • In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. 2016
  • Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. 2015
  • Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. 2014
  • Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis. 2014
  • Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. 2014
  • Suppression of tumor angiogenesis by targeting the protein neddylation pathway. 2014
  • Significance of caveolin-1 regulators in pancreatic cancer. 2013
  • Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. 2013
  • Combinational therapy: new hope for pancreatic cancer? 2012
Show List of Full Article Records
Google Searches

Learn more about Wan-Tong Yao using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Fudan University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2016
  • Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA; · Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; · Department of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Sheikh Ahmed Pancreatic Cancer Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 26883357
  • Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. Electronic address: · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epigenetics and Molecular Carcinogenesis, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan 20139, Italy. · Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Milan 20139, Italy. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. Electronic address: · C-4 Therapeutics, Cambridge, MA 02142, USA. Electronic address: · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27320920
2015
  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of System Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25736685
2014
  • 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [3]. · Department of Medicine, Weill Cornell Medical College, New York, New York 10065, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · 1] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [3] Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pathology Unit, San Raffaele Scientific Institute, Milan 20132, Italy. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine, Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 25119024
  • Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, U.K. · Swiss Institute for Experimental Cancer Research (ISREC), The Swiss Federal Institute of Technology Lausanne (EPFL), Station 19, CH-1015 Lausanne, Switzerland. · Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Biochemistry and Molecular Biology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Cancer Biology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 24954535
Fudan University
2014
  • 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China [3] Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · 1] Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China [2] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. · Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. · State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, Nanjing, China. · Cancer Institute, Fudan University Shanghai Cancer Center; Collaborative Innovation Center of Cancer Medicine; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. · Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · College of Pharmacy, Seoul National University, Seoul, Korea. · AntiCancer Biotech Beijing Co. Ltd, Beijing, China. · Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Surgery, University of California, San Diego, CA, USA [2] AntiCancer, Inc., San Diego, CA, USA. · Pubmed 24525735
2014
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, 270 DongAn Road, Shanghai 200032, P, R, China. · Pubmed 25103363
2013
  • Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China E-mail : · Pubmed 24083692
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China. · Pubmed 23588667
2012
  • Department of Pancreatic and Hepatobiliary Surgery, Fudan University, Shanghai Cancer Center, Shanghai 200032, China. · Pubmed 22138436
  • Department of Pancreas and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. · Pubmed 22354009
Yearly article counts 000214220000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.